News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,164 Results
Type
Article (43676)
Company Profile (274)
Press Release (692200)
Multimedia
Podcasts (149)
Webinars (20)
Section
Business (206549)
Career Advice (2130)
Deals (35814)
Drug Delivery (131)
Drug Development (82825)
Employer Resources (176)
FDA (16644)
Job Trends (15092)
News (350264)
Policy (33183)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2668)
Accelerated approval (43)
Adcomms (30)
Allergies (162)
Alliances (50433)
ALS (197)
Alzheimer's disease (1773)
Antibody-drug conjugate (ADC) (386)
Approvals (16946)
Artificial intelligence (623)
Autoimmune disease (227)
Automation (50)
Bankruptcy (363)
Best Places to Work (11733)
BIOSECURE Act (20)
Biosimilars (203)
Biotechnology (181)
Bladder cancer (179)
Brain cancer (66)
Breast cancer (704)
Cancer (5414)
Cardiovascular disease (452)
Career advice (1802)
Career pathing (39)
CAR-T (308)
CDC (56)
Celiac Disease (2)
Cell therapy (821)
Cervical cancer (42)
Clinical research (71246)
Collaboration (1915)
Company closure (4)
Compensation (1280)
Complete response letters (73)
COVID-19 (2793)
CRISPR (103)
C-suite (979)
Cystic fibrosis (151)
Data (7116)
Decentralized trials (3)
Denatured (75)
Depression (155)
Dermatology (57)
Diabetes (557)
Diagnostics (6972)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (304)
Drug pricing (201)
Drug shortages (30)
Duchenne muscular dystrophy (271)
Earnings (91295)
Editorial (65)
Employer branding (21)
Employer resources (155)
Events (119475)
Executive appointments (1035)
FDA (20090)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1621)
Gene editing (219)
Generative AI (56)
Gene therapy (682)
GLP-1 (1041)
Government (4778)
Grass and pollen (6)
Guidances (396)
Healthcare (19134)
HIV (73)
Huntington's disease (56)
IgA nephropathy (94)
Immunology and inflammation (276)
Immuno-oncology (84)
Indications (157)
Infectious disease (3109)
Inflammatory bowel disease (207)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (275)
Interviews (347)
IPO (16734)
IRA (51)
Job creations (3677)
Job search strategy (1499)
JPM (64)
Kidney cancer (18)
Labor market (95)
Layoffs (571)
Leadership (34)
Legal (8028)
Liver cancer (99)
Longevity (28)
Lung cancer (731)
Lymphoma (412)
Machine learning (52)
Management (61)
Manufacturing (930)
MASH (176)
Medical device (13957)
Medtech (14034)
Mergers & acquisitions (20241)
Metabolic disorders (1431)
mRNA (186)
Multiple sclerosis (175)
NASH (19)
Neurodegenerative disease (392)
Neuropsychiatric disorders (98)
Neuroscience (3195)
Neurotech (1)
NextGen: Class of 2026 (6622)
Non-profit (4598)
Now hiring (73)
Obesity (676)
Opinion (290)
Ovarian cancer (187)
Pain (234)
Pancreatic cancer (257)
Parkinson's disease (343)
Partnered (33)
Patents (560)
Patient recruitment (596)
Peanut (60)
People (59705)
Pharmaceutical (60)
Pharmacy benefit managers (34)
Phase 1 (22149)
Phase 2 (31337)
Phase 3 (23432)
Pipeline (7145)
Policy (317)
Postmarket research (2635)
Preclinical (9445)
Press Release (65)
Prostate cancer (278)
Psychedelics (50)
Radiopharmaceuticals (309)
Rare diseases (1017)
Real estate (6005)
Recruiting (71)
Regulatory (25320)
Reports (55)
Research institute (2486)
Resumes & cover letters (363)
Rett syndrome (32)
RNA editing (22)
RSV (87)
Schizophrenia (166)
Series A (271)
Series B (201)
Service/supplier (11)
Sickle cell disease (107)
Special edition (23)
Spinal muscular atrophy (169)
Sponsored (46)
Startups (3676)
State (2)
Stomach cancer (19)
Supply chain (119)
Tariffs (85)
The Weekly (72)
Vaccines (1099)
Venture capital (103)
Weight loss (437)
Women's health (111)
Worklife (20)
Date
Last 7 days (642)
Last 30 days (2546)
Last 365 days (30226)
2026 (8065)
2025 (30552)
2024 (35616)
2023 (40518)
2022 (51643)
2021 (56197)
2020 (54610)
2019 (47157)
2018 (35573)
2017 (32648)
2016 (32013)
2015 (38043)
2014 (31786)
2013 (26846)
2012 (29019)
2011 (29753)
2010 (27802)
Location
Africa (763)
Alabama (91)
Alaska (7)
Arizona (333)
Arkansas (13)
Asia (40255)
Australia (6634)
California (12322)
Canada (3525)
China (1246)
Colorado (525)
Connecticut (523)
Delaware (366)
Europe (88026)
Florida (1853)
Georgia (395)
Hawaii (3)
Idaho (62)
Illinois (957)
India (81)
Indiana (560)
Iowa (22)
Japan (489)
Kansas (131)
Kentucky (45)
Louisiana (39)
Maine (73)
Maryland (1485)
Massachusetts (8820)
Michigan (347)
Minnesota (678)
Mississippi (6)
Missouri (139)
Montana (33)
Nebraska (29)
Nevada (136)
New Hampshire (82)
New Jersey (3273)
New Mexico (29)
New York (3243)
North Carolina (1581)
North Dakota (8)
Northern California (6099)
Ohio (369)
Oklahoma (22)
Oregon (42)
Pennsylvania (2500)
Puerto Rico (26)
Rhode Island (50)
South America (1144)
South Carolina (77)
South Dakota (1)
Southern California (4830)
Tennessee (199)
Texas (1930)
United States (43646)
Utah (372)
Vermont (1)
Virginia (292)
Washington D.C. (80)
Washington State (990)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
736,164 Results for "expression analysis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis
March 24, 2025
·
4 min read
Press Releases
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
March 12, 2026
·
4 min read
Press Releases
A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression
January 9, 2026
·
5 min read
Press Releases
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
April 2, 2026
·
7 min read
Press Releases
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%
March 19, 2026
·
7 min read
Press Releases
Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis
January 23, 2026
·
2 min read
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
November 18, 2025
·
9 min read
Press Releases
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
December 10, 2025
·
3 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
Previous
2 of 73,617
Next
